Rifampin: a semisynthetic derivative of rifamycin--a prototype for the future.
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000494:pharmacology; D000995:Antitubercular Agents / Q000494:pharmacology; D000998:Antiviral Agents / Q000494:pharmacology; D001419:Bacteria / Q000187:drug effects / Q000201:enzymology; D001424:Bacterial Infections / Q000188:drug therapy; D055598:Chemical Phenomena; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology; D002621:Chemistry; D012321:DNA-Directed RNA Polymerases / Q000037:antagonists & inhibitors; D004352:Drug Resistance, Microbial; D006801:Humans; D007918:Leprosy / Q000188:drug therapy; D008826:Microbial Sensitivity Tests; D012293:Rifampin / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity; D014376:Tuberculosis / Q000188:drug therapy
D000903:Antibiotics, Antineoplastic; D000995:Antitubercular Agents; D000998:Antiviral Agents; D012321:DNA-Directed RNA Polymerases; D012293:Rifampin